Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Healthcare | 13.18% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Mirum Pharmaceuticals
MIRM
$6.02B
| $405K | ﹤0.01% |
23,428
-3,479
| -13% | -$62.3K |
|
3752
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$661M
| $405K | ﹤0.01% |
+25,411
| New | +$393K |
|
3753
Disc Medicine
IRON
$3.07B
| $404K | ﹤0.01% |
2,085
+1,697
| +437% | +$558K |
|
3754
Alkami Technology
ALKT
$2.22B
| $402K | ﹤0.01% |
+11,256
| New | +$413K |
|
3755
Actinium Pharmaceuticals
ATNM
$30.2M
| $402K | ﹤0.01% |
50,793
| – | – |
|
3756
Meridian
MRBK
$240M
| $402K | ﹤0.01% |
30,650
-25,078
| -45% | -$330K |
|
|
CMLS
3757
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $399K | ﹤0.01% |
27,218
| – | – |
|
|
MNTX
3758
DELISTED
Manitex International, Inc.
MNTX
| $399K | ﹤0.01% |
54,761
| – | – |
|
3759
FreightCar America
RAIL
$243M
| $398K | ﹤0.01% |
67,041
-10,920
| -14% | -$66.4K |
|
3760
Unity Bancorp
UNTY
$620M
| $398K | ﹤0.01% |
18,029
-19,837
| -52% | -$446K |
|
3761
Biodesix
BDSX
$251M
| $397K | ﹤0.01% |
1,503
+813
| +118% | +$256K |
|
3762
WisdomTree True Developed International Fund
DOL
$848M
| $397K | ﹤0.01% |
8,049
-8,807
| -52% | -$438K |
|
|
PCOM
3763
DELISTED
Points.com Inc. Common Shares
PCOM
| $397K | ﹤0.01% |
22,845
+430
| +2% | +$7.07K |
|
3764
Consumer Portfolio Services
CPSS
$208M
| $395K | ﹤0.01% |
87,842
| – | – |
|
3765
Laird Superfood
LSF
$48.2M
| $395K | ﹤0.01% |
13,233
+4,672
| +55% | +$157K |
|
3766
Wipro
WIT
$19.4B
| $394K | ﹤0.01% |
100,756
-4,486
| -4% | -$16.7K |
|
|
PPTA
3767
Perpetua Resources
PPTA
$3.1B
| $392K | ﹤0.01% |
+53,766
| New | +$421K |
|
3768
Tenaris
TS
$26.6B
| $392K | ﹤0.01% |
17,924
-1,085
| -6% | -$24.5K |
|
|
ELVT
3769
DELISTED
Elevate Credit, Inc.
ELVT
| $392K | ﹤0.01% |
109,708
-1,920
| -2% | -$6.66K |
|
3770
Celcuity
CELC
$4.22B
| $391K | ﹤0.01% |
+16,308
| New | +$420K |
|
3771
Choiceone Financial
COFS
$515M
| $391K | ﹤0.01% |
16,158
-19,489
| -55% | -$482K |
|
3772
Lantern Pharma
LTRN
$33.6M
| $391K | ﹤0.01% |
26,765
+14,990
| +127% | +$232K |
|
3773
C&F Financial
CFFI
$288M
| $390K | ﹤0.01% |
7,649
-9,631
| -56% | -$452K |
|
3774
Establishment Labs
ESTA
$2.25B
| $390K | ﹤0.01% |
+4,469
| New | +$332K |
|
3775
First Trust Europe AlphaDEX Fund
FEP
$534M
| $387K | ﹤0.01% |
+9,074
| New | +$394K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.